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Abstract Lateral internal sphincterotomy is the surgical
treatment of choice of chronic anal fissure after failure of
conservative measures. Several randomized trials identified
an overall risk of incontinence of 10 % mostly for flatus.
Fissurectomy is the most commonly used procedure to
preserve the integrity of the anal sphincters. However, a
possible complication is keyhole defect that may lead to
faecal soiling. In this study, chronic anal fissure (CAF) was
treated by fissurectomy and anal advancement flap to pre-
serve the anatomo-functional integrity of sphincters and to
reduce healing time and the risk of anal stenosis. In patients
with hypertonia, surgical treatment was combined with
chemical sphincterotomy by injection of botulinum toxin to
enhance tissue perfusion. Forty eight patients with CAF
underwent fissurectomy and anal advancement flap. In 22
subjects with hypertonia of the internal anal sphincter,
intrasphincter injection of 30 UI of botulinum toxin at the
completion of the surgical operation was used. All patients
were followed up to 24 months. Since the first defecation,
the intensity and duration of pain were significantly
reduced. Two patients had urinary retention, five had
infections and three had partial breakdowns. No anal ste-
nosis, keyhole deformity or necrosis flap was recorded. At
the 24 months follow-up visit, anal incontinence was
similar to those detected preoperatively. Only four recur-
rences were detected at 18 and 20 months. After medical
treatment failure, fissurectomy with advancement flap is a
valid sphincter-conserving procedure for treatment of
anterior or posterior CAF, regardless of hypertonia of the
internal anal sphincter.
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Introduction
Anal fissure is a linear split or breach in the lining of the
transition zone between the skin and mucous of the anal
canal. It has an elliptical form, with its major axis vertical
and a size of around 0.5–1 cm. Fissures are classified as
acute or chronic. Acute fissure tends to heal spontaneously
with topical steroids, local anaesthetic and bulk laxatives
within 6 weeks and looks similar to paper [1]. The chro-
nological definition is rather loose, but most surgeons
regard persistence beyond 6 weeks as a reasonable time
when an acute fissure, unlikely to heal with conservative
treatment, may be considered chronic [1]. Morphologi-
cally, the presence of visible transverse internal anal
sphincter fibres at the base of a fissure indicates chronicity
and provides a more clear-cut definition [1]. Associated
features include indurates edges, a sentinel pile and a
hypertrophied anal papilla.
Chronic anal fissure (CAF) is usually associated with
internal anal sphincter (IAS) hypertonia, the relief of which
is considered central to promote fissure healing. First-line
treatment of CAF to decrease hypertonia of the internal
anal sphincter is medical. After pharmacological sphinc-
terotomy, the healing rate of CAF ranges from 30 to 96 %,
whereas transitory minor incontinence for flatus and soiling
has been reported in a few cases. Surgical treatment gen-
erally recommended is anal lateral sphincterotomy that
seems to be the manoeuvre of choice after the failure of
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conservative treatment resulting in success rates above
95 % [2]. However, it may cause incontinence. As indi-
cated by Nelson [3] in a recent systematic review of ran-
domized surgical trials, after sphincterotomy the overall
risk of incontinence is about 10 %, mostly to flatus without
any specification of the duration of this problem (transitory
or permanent). However, it is a common belief that the risk
of permanent incontinence is about 1 %. Nonetheless, this
does not take into account the normal weakening of the
sphincter with age and the possibility of future anorectal
surgery, radiation or obstetrical trauma. Therefore, the risk
of incontinence after lateral internal sphincterotomy should
be taken into account looking at the life span of the patient
[4].
Fissurectomy is the procedure most used to preserve the
integrity of anal sphincters, although it has been rarely used
alone. In fact, the possible complication of keyhole defect
that may lead to faecal soiling limits its use. Recently, to
reduce the incidence of complications, it has been associated
with pharmacological sphincterotomy or with advancement
flap showing good results.
The aim of this study was to evaluate the efficacy of
fissurectomy with anal advancement flap in the treatment
of CAF. The primary end point was fissure healing and the
secondary end point included symptoms relief (bleeding,
pain, pruritus) and immediate and long-term complications
(incontinence, anal stenosis, keyhole deformity, urinary
retention and recurrence).
Materials and methods
From January 2002 to January 2008, 106 patients who
failed medical therapy underwent surgical treatment: 48
subjects underwent fissurectomy and anal advancement
flap; the remaining 58 patients were treated with a tailored
sphincterotomy. Since 2002, 26 patients with anterior and
posterior CAF without hypertonia of IAS underwent fis-
surectomy combined with V–Y advancement flap [5, 6],
while 10 patients with anterior CAF and hypertonia of IAS
underwent fissurectomy combined with advancement flap
and injections of 30 UI of botulinum toxin [7]; posterior
CAF with hypertonia was treated with a tailored sphinc-
terotomy. According to positive results obtained since
2006, a further 12 patients with posterior CAF and
hypertonia of IAS underwent fissurectomy combined with
anal advancement flap and injection of 30 UI of botulinum
toxin (Table 1).
All subjects gave written informed consent and the local
ethics committee approved the study. Exclusion criteria
were the presence of multiple and lateral fissures, chronic
fistulas in ano, syphilis, inflammatory bowel disease, anal
abscess or malignant disease. CAFs resistant to medical
treatment were defined as those that failed healing after
well-practised topical medical therapy and high fibre die-
tary supplementation. Preoperative anorectal manometry
was performed after appropriate time of cessation of
medical treatment. The manometry was carried out by a
manometric sensor with 2.1 mm external diameter with
four circle orifices and with a latex microballoon at its
extremity (Marquat C87, Boissy, St-Leger, France). The
machine was connected to a polygraph (Narco, Byo-Sys-
tem MMS 200, Houston, TX, USA), using the station pull-
through method with perfusion of normal saline and the
patient lying in the right lateral position. Maximum resting
pressure (MRP) was defined as maximum pressure detected
on resting. Data collected by our anorectal pathophysiology
laboratory, according to others [8], showed that the normal
range of MRP values was from 45 to 85 mmHg. CAFs
without hypertonia have been defined as those in which
MRP values are \85 mmHg [8]. All patients underwent
fissurectomy in the gynaecological position under spinal
anaesthesia. An Eisenhammer anal speculum was gently
inserted into the anal canal. After injection of 5 ml of a
local anaesthetic solution constituting 100 mg of cloridrate
mepivacain and 0.025 mg of L-adrenaline, the fibrotic
edges were excised with a scalpel until a normal non-
fibrotic anodermal tissue showed sufficient bleeding. The
sentinel skin tag and hypertrophied papilla at the level of
dentate line when present were excised. The granulation
tissue at the base of the fissure was curetted until there were
clean muscle fibres of the IAS. There was no use of dia-
thermy and careful attention was given not to damage the
IAS. Standard advancement flap was performed using a
flap of healthy skin tissue extending from about 2–3 cm
from the anal verge, which was mobilized and then
advanced with its blood supply to fill the defect. The flap
was secured without tension to the anal canal and the skin
was closed tension free in a V–Y manner with rapid
absorbable suture behind the advanced flap. In patients
with anterior and posterior CAF with hypertonia of the
IAS, after the fissurectomy and the anal advancement flap,
an injection of botulinum toxin A (Botox, Allergan,
Westport, Ireland) stored at -20 C and diluted in saline to
50 UI/ml was performed into IAS with a 27-gauge needle.
Each patient received a total of 30 UI of botulinum toxin
Table 1 Site, tone of internal anal sphincter of 48 chronic anal fis-
sures (CAFs) treated with sparing saving sphincter procedures
CAF site Sphincter tone no % Treatment
Anterior Normo-hypotonia 16 33 F ? A
Posterior Normo-hypotonia 10 21 F ? A
Anterior Hypertonia 10 21 F ? A ? Tox
Posterior Hypertonia 12 25 F ? A ? Tox
A anal advancement flap, F fissurectomy, Tox botulinum toxin
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equally divided on either side of the midline. According to
others, the site of injection depends on the location of the
fissure and it should be anterior for posterior fissure and
posterior for anterior ones [9]. None of the patients
assumed concomitant oral medications that could interfere
with the action of type A botulinum toxin (aminoglyco-
sides, baclofen, dantrolene, diazepam) and there was no
known hypersensitivity to any component of botulinum
toxin formulation. Before surgery, all patients received a
small volume of phosphate-saline enema. Metronidazole
was administered intravenously at a dose of 500 mg 1 h
before surgery. Subsequently, it was administered per os at
the dosage of 250 mg for 7 days three times daily. During
the first 2 weeks after the operation, patients took variable
doses of psyllium fibre. A laxative preparation (sennosides)
was given orally to subjects who had not yet passed stools
3 days after surgery. Enema, suppositories and all rectal
manipulations were avoided. Immediately after surgery, all
patients received 100 mg of diclofenac intramuscularly
for analgesia and were instructed to take only 100 mg of
nimesulide tablets as requested. Fissure healing was
defined as a complete epithelization of the advancement
flap. Both duration and intensity of pain post-defecation
were evaluated after surgical treatment. Pain intensity was
scored with a visual analog scale (VAS) from 0 to 10,
where 0 corresponded to no pain and 10 to the worse pain
conceivable [10]. Patients were discharged 24–48 h after
surgery; afterward, they were examined in the outpatient
clinic until the anal wound was completely healed. All
patients were followed up to 24 months after surgery. The
controls were made at distance of 1, 6, 12 and 24 months.
Anal incontinence was assessed using the Pescatori grading
system: A, incontinence for flatus and mucus; B, liquid
stool; C, solid stool; and 1 for occasional, 2 for weekly and
3 for daily [11]. Independently of these scheduled
appointments, patients were seen on request.
Statistical analysis
Continuous variables were expressed as mean and standard
deviation, and qualitative data as absolute frequencies.
Student’s t test with Welch correction was used to analyse
the differences of pain score and pain duration at each
registration point. Values of p \ 0.05 were considered to
be statistically significant.
Results
Baseline characteristics of patients
The enrolled patients included 32 females and 16 males
with a median age of 37 years (range 18–65). Bowel
habitus was normal in 10 patients, constipation was
detected in 36 subjects and diarrhoea in 2 patients in
accordance with updated Rome diagnostic criteria, previ-
ously published [12]. Ten females were nulliparous,
whereas 12 had given birth vaginally one time or more and
10 had caesarean delivery. The mean duration of symptoms
was 12.3 ± 5.1 months. In 83 % of the cases, the CAF had
an hypertrophied anal papilla and in 73 % of cases skin
tags occurred. The more frequent symptom was pain
(96 %), whereas bleeding and pruritus occurred, respec-
tively, in 83 and 52 %.
The localization of CAF was anterior in 26 patients and
posterior in 22; in 26 cases, there was normo-hypotonia.
The unusually high rate of female sex and anterior CAF
was due the fact that in our previous study design, the
original indication to the advancement flap after fissurec-
tomy was reserved only for female patients with anterior
CAF (5). All patients underwent fissurectomy and V–Y
advancement flap. Twenty two patients with hypertonia of
the IAS were treated with injection of 30 U of botulinum
toxin (Table 1).
Healing fissure and relief of symptoms
All patients healed completely within 30 days after oper-
ation. None of the patients had diarrhoea and only two
patients were referred for two defecations only in 1 day
during the assessment time. The intensity and the duration
of pain post-defecation was reduced significantly with
respect to the preoperative values starting from the first
defecation (p \ 0.0001) (Fig. 1). None of the patients
complained of pain, bleeding or pruritus 30 days after
surgery. Analgesics consumption decreased significantly
after the first defecation.
Anal continence
Preoperatively, seven patients were referred for anal
incontinence. Among them, according to the Pescatori
grading system [11], one subject was classified as A1, five
Fig. 1 Intensity and duration of pain related to defecation after
fissurectomy and anal advancement flap
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as A2 and one as A3. One month after surgery, anal
incontinence was referred in ten patients. At 24 months,
only six patients referred to incontinence: three as A1, two
as A2 and one as A3 (Table 2); at the initial presentation,
all the six patients had complained of incontinence.
Complications and follow-up
Only minor complications were observed; in particular,
five cases of infection and three of partial breakdown
occurred. In all cases, the infection was superficial and did
not need antibiotics administration. Two patients suffered
from urinary retention. There were no cases of anal stenosis
or keyhole deformity. No necrosis of the transposed flap
was observed (Table 3).
At 24 months of follow-up, four recurrences were
recorded (8 %). In two cases, primitive CAF was anterior
without hypertonia of IAS; their recurrence was localized
posteriorly with a normal value of IAS. In the third case,
primitive CAF was anterior with hypertonia of IAS and the
recurrence was lateral without hypertonia; the last patient
had posterior primitive CAF with hypertonia of IAS and its
recurrence was anterior with hypertonia. All patients with
recurrence of CAF underwent medical treatment with
improvement or healing.
Discussion
The data from this study underline that by avoiding
sphincterotomy using a technique that preserves sphincter
activity, good results may be achieved. In fact, all patients
healed within 30 days from operation. At the 24-month
follow-up, six patients reported anal incontinence that was
already present before the surgical operation and there
were only four recurrences. We have reported a low inci-
dence of complications and no surgical re-operation was
needed. Although wound infection and flap breakdown are
known complications of anal advancement flap, in this
study the incidence of breakdown was 3/58 cases (5.1 %)
in accordance with rates reported in the literature by
Giordano et al. (5.9 %) [13], Chambers (5.5 %) [14] and
Patel et al (8 %) [15]. On the other hand, the incidence of
infection was 5/58 cases (8.6 %), similar to that reported
by Patel (8 %) [15].
Until now, the role of hypertonia of IAS is unclear: if it
is a cause or an effect of CAF. During the last few decades,
the treatment was aimed to reduce sphincter hypertonia
with medical or surgical techniques. The first-line treat-
ment of CAF is medical. However, surgical sphincterotomy
represents the treatment of choice in case of failure of
conservative measures. The sphincterotomy was described
in 1951 by Eisenhammer; partial division of the internal
sphincter muscle posterior has been a popular treatment for
anal fissure for nearly two decades. However, several
studies have reported prolonged healing times, postopera-
tive pain and keyhole deformity [2]. Therefore, today this
procedure is used rarely. In 1969, Notaras proposed lateral
internal sphincterotomy. This technique is associated with
fewer complications than posterior sphincterotomy, with
immediate improvement of pain and success rate above
95 % [2]. However, it is associated with significant inci-
dence of postoperative incontinence ranging between 0 and
35 % for flatus, 0 and 21 % for liquid, and 0 and 5 % for
solid stools [4] with an overall incontinence risk as high as
10 % [3]. Variations could be due to operative technique,
length of follow-up or criteria used to define anal inconti-
nence [16]. Nowadays, it is well known that faecal
incontinence may occur many years after sphincter damage
(i.e. anorectal surgery, radiation or obstetrical trauma). To
minimize this risk, several authors have tried a more lim-
ited division of internal sphincter, a tailored or controlled
sphincterotomy [17, 18]. Tailored sphincterotomy reduces
the risk of incontinence, but may increase the incidence of
recurrence [17, 18].
Fissurectomy is the surgical procedure most used to
preserve structural and functional integrity of the IAS.
Fissurectomy is the excision of the anal fissure and it can
be associated with the removal of the hypertrophied anal
papilla and the skin tags. Fissurectomy, as a wound
debridement, removes the bradytrophic scar tissue and
produces fresh wound edges, creating in essence an acute
fissure. Fissure excision without a procedure on the IAS
is an old operation and was supported by Ashton in 1854.
Table 2 Patients with anal incontinence according to Pescatori
grading score before and after surgical operation
Time A1 A2 A3 Total
Preoperative 1 5 1 7
At 1 month 3 5 2 10
At 6 months 4 3 1 8
At 12 months 3 3 1 7
At 24 months 3 2 1 6
Table 3 Postoperative complications and number of recurrences
Complications Total %
Urinary retention 2 4
Anal stenosis – –
Keyhole deformity – –
Infection 5 10
Breakdown 3 6
Necrosis flap – –
Recurrences (24 months) 4 8
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It was recognized as effective therapy for CAF for many
years and afterwards it was abandoned due to its conse-
quences, such as keyhole deformity that may lead to faecal
incontinence [16]. Nevertheless, it has recently been
reconsidered for treating CAF both in children and in
adults with success [19–21]. To improve the results and to
reduce the incidence of complications, the fissurectomy has
been associated with pharmacological sphincterotomy.
This treatment includes the advantages of fissurectomy as
well as those of pharmacological sphincterotomy. Engel
et al. [22] first described the combination of fissurectomy
associated with chemical sphincterotomy. They combined
local isosorbide dinitrate with fissurectomy in 15 patients
and described healing rates of 100 % within a follow-up of
29 months [22]. Few recent studies [4, 23–28] describe a
combination of botulinum toxin A injections and fissurec-
tomy with excellent results. This procedure allows healing
by secondary intention, because it leaves the fissurectomy
wound open. Only Witte et al. [28] prepared wound edges
after fissurectomy and sutured it with absorbable sutures,
reducing the time of healing.
To cover the exposed area after fissurectomy, an
advancement skin graft has been mostly used. Only
recently, a mucosal advancement flap has been used [29,
30]. The rationale of advancing flaps of skin and fat is
based on introducing fresh blood supply to the ischaemic
area of the fissure [2], reducing the time required for per-
ianal wound healing and avoiding the risk of anal stenosis
that follows healing by scarring [16]. This procedure has
been performed selectively on patients with CAF without
hypertonia of IAS [5, 6, 31–33] or extensively, indepen-
dently of CAF side and sphincter tone [13, 14, 34–36]. The
results obtained have been good; in particular, a high
healing rate, reduced incidence of complications and
recurrences and complete preservation of anal continence
have been reported. In patients with dermal flap, Hancke
et al. [36] in a comparative study between dermal flap
coverage and lateral internal sphincterotomy reported a
significant reduction of anal incontinence. However, to
date published reports have been based only on a small
sample size; only one study published in 1970 analysed a
high number of procedures [35]. Giordano et al. [13] and
Chambers et al. [14] showed excellent results, giving solid
evidence that fissurectomy with anal advancement flap may
be used as first-line treatment for all the CAFs.
Fissurectomy combined with anal advancement flap and
injection of 30 UI of botulinum toxin in patients with
posterior CAF with hypertonia of IAS, which until now has
been used only by us, shows how the temporary reduction
of the IAS tone, after injection of botulinum toxin,
improves bloody flow and permits rooting of skin graft. At
24 months, there were only four recurrences not localized
at the same initial sites. This occurrence is perhaps
testament of the durability of the flap. The event that
subsequently four patients developed new fissures sug-
gests that this technique does not remove presumed causes
of fissure like defecatory habit, stool consistency and
sphincter tone [13]. According to other authors [31, 33–35],
there was not a new case of incontinence; in fact, six
patients with incontinence reported it before the surgical
operation.
The studies on CAF treatment after failure of conser-
vative measures using surgical techniques of sphincter
sparing show excellent results in terms of healing rates and
incidence of incontinence and recurrence. In conclusion,
although some studies showed excellent results for the
treatment of CAF independent of site, sex and sphincter
tone, to date it seems opportune to offer fissurectomy
combined with anal advancement flap only in patients with
anterior CAF, in female patients and/or in the case of
recurrence after sphincterotomy and after surgical opera-
tion in ano.
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